Prawo i regulacje · 21/02/2017

Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, as Recommended by the Committee on Foreign Investment in the United States

The Federal Trade Commission has approved Pfizer's acquisition of BioNTech, a deal worth $68 billion, following a review by the Committee on Foreign Investment in the United States, which recommended the approval